Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1226, 2000-01, pp. : 13-13
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Endocrine therapy for younger women with breast cancer?
Inpharma, Vol. 1, Iss. 1254, 2000-01 ,pp. :
Access to resources
Recommend
Perioperative chemotherapy beneficial in early breast cancer?
Inpharma, Vol. 1, Iss. 1321, 2002-01 ,pp. :
Tamoxifen plus chemotherapy worth it in early breast cancer?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 354, 2002-01 ,pp. :
Tamoxifen plus chemotherapy worth it in early breast cancer?
Inpharma, Vol. 1, Iss. 1329, 2002-01 ,pp. :
HRT `safe' for use in women with breast cancer?
Inpharma, Vol. 1, Iss. 1365, 2002-01 ,pp. :